NCT04039373View on ClinicalTrials.gov

Effects of BMS-986256 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate Mofetil

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 22, 2019

Primary Completion Date

September 18, 2019

Study Completion Date

October 16, 2019

Conditions
Healthy Participants
Interventions
DRUG

BMS-986256

specified dose on specified days

DRUG

Mycophenolate Mofetil

specified dose on specified days

Trial Locations (1)

84124

PRA Health Sciences - Salt Lake, Salt Lake City

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY